wall street

Biologics

Josh SandbergJune 15, 2015
1,625

3 Big Healthcare Trends Wall Street Is Overlooking

By Cheryl Swanson The chief market strategists at Wall Street’s biggest banks and investment firms don’t get things right all…
Read More »
Financial

Josh SandbergMay 23, 2015
1,960

Analyst: ConMed ripe for M&A spree

By Fink Densford ConMed could be poised for some merger & acquisition activity as new management engineers a turnaround, according…
Read More »
Financial

Josh SandbergApril 23, 2015
1,333

St. Jude Medical’s Q1 beats own guidance and Wall Street’s

By Brad Perriello St. Jude Medical’s 1st-quarter earnings top both its own guidance and Wall Street’s outlook, prompting the medical…
Read More »
Financial

Josh SandbergApril 15, 2015
1,773

Wall Street Places $54.5 Price Target on NuVasive, Inc. (NASDAQ:NUVA)

By Seth Talluto In looking at the consensus numbers, the sell-side analysts covering the stock have a mean target price…
Read More »
Financial

Josh SandbergAugust 28, 2013
972

Medtronic’s Maneuvers May Signal Long-Term Struggles For Industry

Wall Street analysts warn that Medtronic’s moves into disease management signal “challenging times ahead for device manufacturers.” When Medtronic (NYSE:MDT) announced that…
Read More »